Navigation Links
The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System

ibrium after approximately 7 h and was stable for at least a further 5 h as demonstrated by the results shown in Figure 4.

Z′analysis
Finally, a Z′analysis was performed using 48 replicate values each for "total" and NSB wells, Z′was determined to be 0.83 (Fig 5), which confirmed the robustness of the assay (5).


Conclusions
The CXCR2 chemokine receptor-binding assay has been successfully miniaturized to a 384-well format using the LEADseeker Multimodality Imaging System and is suitable for adaptation to automated screening formats. The assay is tolerant to DMSO up to a concentration of 12.5% (v/v), robust; achieving a Z′value of 0.83, and has a stability window of at least 5 h.


References
1. Rossi, D. and Zlotnik, A. Annual Review Immunology 18, 217–242 (2000).

2. Premack, B. A. and Schall, T. J. Nature Medicine 2, 1174–1178 (1996).

3. Addison, C. L. et al. Journal of Immunology, 165, 5269–5277 (2000).

4. Clark-Lewis, I. et al. Journal Biological Chemistry 278 (1), 289–295 (2003).

5. Zhang, J. et al. Journal Biomolecular Screening 4 (2), 67–73 (1999).



back to top
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
2. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
3. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
4. The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System
5. The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System
6. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
7. LiquiChip Kits for bead-based cytokine and kinase assays
8. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
9. High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system
10. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
11. Principles of Curve Fitting for Multiplex Sandwich Immunoassays, Rev B

Post Your Comments:
(Date:11/30/2009)..., SHANGHAI, Nov. 30 /PRNewswire-Asia/ -- WuXi ..., biotechnology, and medical-device research and,d...China and the United States,announced that it had...China,2009 list for the fifth consecutive year. Th... in China,s technology, media, and telecommunicati...
(Date:11/27/2009)..., DURHAM, N.C., Nov. 27 Cromoz In...te water-soluble carbon nanotube-based cancer drug...luble carbon nanotubes, which have functional grou...ancer drugs, was developed in partnership with the...carbon nanotubes serves as a drug delivery vehicle...
(Date:11/25/2009)..., BOSTON, Nov. 25 Biotech firm Re...enomic data from the 1918 pandemic through the pre...1 pandemic, today issued its latest biochemical an...ethality of the H1N1 ("Swine Flu") virus has dropp...s,s current outbreak in the spring of 2009 to rest...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.... available in its catalogue: ,, Brazil Bioetha...http://www.reportlinker.com/p0165503/Brazil-Bioeth..., Brazil Bioethanol Market Analysis and Forecas...es detailed analysis and forecasts of the global b...
Breaking Biology Technology:WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10
... at the 7th International Sympo...Sept. 8 ESBATech AG, a leading,developer of antib...e,company has successfully completed its Phase I c...ate, ESBA105, in ophthalmic indications. In,April ...d to evaluate the,safety, tolerability and pharmac...
...ctable HCV RNA levels, following 4 weeks of treatm... Copegus(R) -, - Safety a... with Pegasys plus Cop....,(Nasdaq: VRUS ) announces the preliminary resul...of-concept clinical trial evaluating R7128 1500mg,...
...onsulting announced that it has appointed A.J. Wha... Charlotte, NC (PRWEB) September 8, 2008 -- ww...nsulting] announced that it has appointed A.J. Wha...s Symphony from Wellesley Information Services (WI...ing, and producing national educational conference...
Other Biology Technology:ESBATech Announces Successful Completion of Phase I Clinical Study for Lead Antibody Fragment in Ophthalmic Indications 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 2Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 3Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 4Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 5Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders 6Symphony Managemnt Consulting Hires New Solutions Director 2
(Date:11/30/2009)... Neurotechnology ( http://www.neur...ometric identification technologies, has released ...e: VeriLook 4.0 Software Development Kit (SDK) f...r large-scale multi-biometric and automated finger...bilities in VeriLook 4.0 provide enhanced facial r...
(Date:11/26/2009)...ries has shown that closing schools in the event o...ificant role in reducing illness transmission. Res...nfectious Diseases compared opportunities for inf...ng that they were reduced when schools are shut. ,... Belgium, led a team of European researchers in us...
(Date:11/25/2009)...may be used to boost resistance to, or slow, the d...Medicine researchers report in a study published i... , Parkinson,s disease is caused by a degenerati...known as the substantia nigra, which is responsibl...dopamine in late-stage Parkinson,s causes symptoms...
Breaking Biology News(10 mins):New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 2New VeriLook 4.0 for Biometric Facial Recognition and MegaMatcher 3.1 for Multi-biometric Applications Are Now Available 3School closure could reduce swine flu transmission by 21 percent 2Hormone ghrelin can boost resistance to Parkinson's disease 2Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 1Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 2Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 3Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 4Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 5Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 6Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 7Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 8Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 9Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 10Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 11Reportlinker Adds Vaccines 2009 3A World Market Analysis Key Players and Critical Trends in a Fast Changing Industry Report 58002 12Medelis Expands CRO Services to Medical Devices Appoints Dr Inder Makin as VP 14211 1Medelis Expands CRO Services to Medical Devices Appoints Dr Inder Makin as VP 14211 2Medelis Expands CRO Services to Medical Devices Appoints Dr Inder Makin as VP 14211 3FaxBack Announces New HTTPS Fax Platform 57999 1FaxBack Announces New HTTPS Fax Platform 57999 2FaxBack Announces New HTTPS Fax Platform 57999 3
...cientists in Belgium have discovered how to clone ...the laboratory. Their discovery should make it eas...ines from cloned embryos and develop them to provi...annual conference of the European Society of Human...0 June). , Until now, scientists investigating hum...
... method for identifying Bacillus anthracis, the ca...gnostic use by the U.S. Food and Drug Administrati..., was modified by scientists at the U.S. Army Medi...MRIID) to improve its performance and reliability ...rm of the Gamma Phage Assay was first developed by...
...cientists at The Scripps Research Institute have s...em molecule called TLR3, an acronym for Toll-like ...l Science, the protein is described as a large hor...eats (LRRs). , The structure reveals details of T... step toward fully understanding the critical role...
Other Biology News:Scientists succeed in cloning human embryos from eggs matured in the lab 2Scientists succeed in cloning human embryos from eggs matured in the lab 3'Mad cow' proteins successfully detected in blood 2'Mad cow' proteins successfully detected in blood 3Scripps research scientists solve structure of a critical innate immune system protein 2Scripps research scientists solve structure of a critical innate immune system protein 3Scripps research scientists solve structure of a critical innate immune system protein 4
...far-infrared range FT-IR spectrometers give you th...lass. Yet all this comes at an amazingly affordabl...ving a larger and faster mirror closer to the sour...300%,larger solid angle of energy into the interfe...
... measure three fluorescence lifetimespicoseconds t...es. To match the absorption maxima of the amino ac...xcitation source is the powerful NanoLED-17, a pul...han is widely used as a probe of protein structure...
...were designed for full-length gene cloning and req...ed cDNA clone. The first PCR analysis is performed...ains plasmid DNA from 5,000 clones. Having identif... the reaction products, the second PCR analysis is...
...were designed for full-length gene cloning and req...ed cDNA clone. The first PCR analysis is performed...ains plasmid DNA from 5,000 clones. Having identif... the reaction products, the second PCR analysis is...
Biology Products: